176 related articles for article (PubMed ID: 17898669)
1. Parenteral versus oral treatment of postmenopausal women with estrogen.
Stanczyk FZ
Menopause; 2007; 14(6):968-70. PubMed ID: 17898669
[No Abstract] [Full Text] [Related]
2. Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women.
Flaumenhaft R; Nachtigall M; Lowenstein J; Nachtigall L; Nachtigall R; Nachtigall L
Menopause; 2009; 16(2):407-12. PubMed ID: 18989235
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic role of estrogens in postmenopausal women.
Freeman R; Lewis RM
Endocrinol Metab Clin North Am; 2004 Dec; 33(4):771-89. PubMed ID: 15501645
[TBL] [Abstract][Full Text] [Related]
4. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
Clarkson TB; Karas RH
Menopause; 2007; 14(6):963-7. PubMed ID: 17909452
[No Abstract] [Full Text] [Related]
5. The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.
Marque V; Alhenc-Gelas M; Plu-Bureau G; Oger E; Scarabin PY
Thromb Haemost; 2001 Aug; 86(2):713-4. PubMed ID: 11522028
[No Abstract] [Full Text] [Related]
6. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
Fait T; Vrablik M; Zizka Z; Kostirova M
Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
[TBL] [Abstract][Full Text] [Related]
7. Different effects of oral and transdermal estrogen replacement therapy on matrix metalloproteinase and their inhibitor in postmenopausal women.
Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1948-9. PubMed ID: 14555643
[No Abstract] [Full Text] [Related]
8. Tailor made.
Freeman SB
Adv Nurse Pract; 2006 Jun; 14(6):57-8, 60-2. PubMed ID: 16972461
[No Abstract] [Full Text] [Related]
9. Transdermal hormone replacement therapy: its value in various clinical situations. Introduction.
Br J Clin Pract Suppl; 1996 Sep; 86():i. PubMed ID: 8995001
[No Abstract] [Full Text] [Related]
10. The sexual health benefits of oral low-dose estrogen plus progestogen and vaginal estrogen for postmenopausal women.
Kingsberg SA
Menopause; 2009; 16(2):224-5. PubMed ID: 19188846
[No Abstract] [Full Text] [Related]
11. Oestrogen therapy: oral versus non-oral administration.
von Schoultz B
Gynecol Endocrinol; 2009 Sep; 25(9):551-3. PubMed ID: 19479596
[No Abstract] [Full Text] [Related]
12. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H
Menopause; 2008; 15(2):352-6. PubMed ID: 18090872
[TBL] [Abstract][Full Text] [Related]
14. Getting estrogen through the skin.
Harv Womens Health Watch; 1998 Dec; 6(4):2-3. PubMed ID: 9846142
[No Abstract] [Full Text] [Related]
15. [Urogenital complaints: value of systemic estrogen therapy].
Hänggi W; Dörflinger A
Praxis (Bern 1994); 1997 Aug; 86(33):1260-3. PubMed ID: 9381012
[TBL] [Abstract][Full Text] [Related]
16. Estrogen for vulvovaginal symptoms: how low can you go?
Brzezinski A; Benshushan A
Menopause; 2009; 16(5):848-50. PubMed ID: 19564805
[No Abstract] [Full Text] [Related]
17. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral estrogen on substrate utilization in postmenopausal women.
Lwin R; Darnell B; Oster R; Lawrence J; Foster J; Azziz R; Gower BA
Fertil Steril; 2008 Oct; 90(4):1275-8. PubMed ID: 18001731
[TBL] [Abstract][Full Text] [Related]
19. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
[No Abstract] [Full Text] [Related]
20. Transdermal versus oral estrogen for postmenopausal replacement therapy.
Bauwens SF
Clin Pharm; 1989 May; 8(5):364-6. PubMed ID: 2663327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
